Sex: male | 49 | NS | |
Age >65 y | 41 | NS | |
First symptom | | | |
Acute pancreatitis | 20 | NS | |
Abdominal pain | 13 | 0.004 | 3.3 (1.4 to 7.7) |
Jaundice | 12 | NS | |
CEA (n=38)† ≥2N | 6 | NS | |
CA 19.9 (n=46)† ≥2N | 17 | 0.02 | 2.7 (1.1 to 6.6) |
Tumour location | | | |
Head/corpus | 49 | 0.01 | 0.3 (0.1 to 0.8) |
Tail | 14 | 0.04 | 2.3 (1.0 to 5.2) |
Diffuse | 6 | NS | |
Duct involvement | | | |
Main duct or combined | 65 | NS | |
Secondary ducts only | 8 | NS | |
Tumour size (n=60)† >30 mm | 21 | NS | |
Pathology | | | |
In situ carcinoma | 22 | 0.01 | 6.3 (1.5 to 27.0) |
Invasive carcinoma | 51 | | |
Pancreatic cut surface | | | |
Normal | 50 | NS | |
Hyperplasia | 9 | NS | |
Atypical hyperplasia | 7 | NS | |
In situ carcinoma | 4 | NS | |
Invasive carcinoma | 3 | NS | |
Colloid form (n=51)† | 33 | NS | |
Lymph node metastases | 17 | 0.0001‡ | 7.5 (3.4 to 16.4) |
Peripancreatic extension: T3 | 12 | 0.01 | 2.8 (1.2 to 6.8) |
Malignant relapse | 28 | 0.0001 | 9.0 (3.4 to 24.0) |
Adjuvant treatment: radio/chemotherapy | 7 | NS | |
Centre | | | |
Clichy | 24 | NS | |
Lyon | 23 | NS | |
Paris | 20 | NS | |
Marseille | 6 | NS | |